Oncobiologics, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Oncobiologics, Inc.
CIK #0001649989
EDGAR Form CIK 2011 - 2025
10-K [0001649989]
10-Q [0001649989]
3 [0001649989]
4 [0001649989]
8-K [0001649989]
D [0001649989]
SC 13D [0001649989]
SC 13G [0001649989]
Form 13D/13G Filer Form 13D/13G Subject Filed
Empery Asset Management LP Outlook Therapeutics Inc [2025-07-31]
Sphera Funds Management Ltd Outlook Therapeutics Inc [2025-03-03]
Great Point Partners LLC Outlook Therapeutics Inc [2024-04-08]
Velan Capital Investment Management LP Outlook Therapeutics Inc [2024-03-28]
Tang Capital Partners LP Outlook Therapeutics Inc [2024-03-28]
GMS Ventures & Investments Outlook Therapeutics Inc [2022-07-07]
Hope Jason Outlook Therapeutics Inc [2022-04-01]
Syntone Ventures LLC Outlook Therapeutics Inc [2020-06-12]
Armistice Capital LLC Outlook Therapeutics Inc [2020-03-05]
Sabby Management LLC Outlook Therapeutics Inc [2020-02-24]
View All
Form 3/4/5 Subject 2011 - 2025
Jahr Robert Charles
Outlook Therapeutics, Inc.
Sukhtian Ghiath M.
GMS Ventures & Investments
Sukhtian Faisal Ghiath
Gangolli Julian S
Huang Andong
Auffarth Gerd
Haddadin Yezan Munther
Hilzinger Kurt J
Thurman Randy H
Haller Julia A
Kenyon Lawrence A
Syntone Ventures LLC
Trenary C Russell III
Evanson Jeff
Dagnon Terry
BioLexis Pte Ltd.
Pillai Arun Kumar
Thomas Joe
Bahrt Kenneth
Mohan Pankaj
Windisch Joerg
McAndrew Stephen J
Yamashita Elizabeth A.
Albrecht Claudio
Brady Todd C
Canute Scott A
Dyrness Albert D.
Gangloff Scott A.
Bao Kogan
Smith Hoke Robin
Griffith Donald J.
Terms | Privacy | Guide
tony@aum13f.com